D. Boral Capital Reiterates Buy Rating for VolitionRx (NYSE:VNRX)
VolitionRx (NYSE:VNRX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at D. Boral Capital in a research report issued on Monday,Benzinga reports. They currently have a $5.00 price objective on the stock. Separately, StockNews.com assumed coverage on shares of VolitionRx in a research report on Friday, March 28th. They issued a […]
VolitionRx (NYSE:VNRX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at D. Boral Capital in a research report issued on Monday,Benzinga reports. They currently have a $5.00 price objective on the stock. Separately, StockNews.com assumed coverage on shares of VolitionRx in a research report on Friday, March 28th. They issued a […]
